News of Note—Sanofi's Dengvaxia, HPV vaccine and more

newspaper
(Pixabay)

Here is some other vaccine news of note for the week.

> Dengvaxia's safety scandal in the Philippines lowered confidence in vaccines overall in the country. Release

> A study found that teenage girls are not more likely to engage in risky sexual behavior if they receive the HPV vaccine. Newsweek article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Inovio Pharmaceuticals' Ebola vaccine candidate elicited immune responses in a preclinical study. Release

> The Walter Reed Army Institute of Research kicked off an early stage trial of a vaccine candidate against Marburg virus. Release

> Valneva advanced its Chikungunya vaccine candidate to the next stage within a phase 1 trial program. Release